Atlas Trials

Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)

Clinical trial NCT02926300 · UNKNOWN

Trial details

NCT number
NCT02926300
Sponsor
Kang Stem Biotech Co., Ltd.
Status
UNKNOWN
Study type
OBSERVATIONAL
Crohn's Disease
Start date
2015-11-01
Primary completion
2021-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.